ข่าวประชาสัมพันธ์ คิววัน+ไซแอนติฟิก+Q1+Scientific

BioNet Receives Positive CHMP Opinion from EMA for VacPertagen, a Recombinant Vaccine Against Pertussis

BioNet, a biotechnology company dedicated to innovative vaccines, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion under the centralised procedure recommending marketing authorisation for VacPertagen for booster immunisation in individuals 12 years onwards and passive immunisation during pregnancy. Prof. Emeritus Stanley Plotkin , Chairman of BioNet's Scientific Advisory Board and an eminent

Adjunct Professor Thanphuying Dr. Petchar... The 13th Annual Scientific Meeting of the Royal College of Dental Surgeons of Thailand — Adjunct Professor Thanphuying Dr. Petchara Techakampuch (4th from...